search
Back to results

A Study of Nivolumab in Advanced Non-Small Cell Lung Cancer (NSCLC) (CheckMate370)

Primary Purpose

Non-Small Cell Lung Cancer

Status
Completed
Phase
Phase 1
Locations
United States
Study Type
Interventional
Intervention
Nivolumab
Bevacizumab
Pemetrexed
Best Supportive Care
nab-Paclitaxel
Paclitaxel
Docetaxel
Gemcitabine
Erlotinib
Crizotinib
Carboplatin
Sponsored by
Bristol-Myers Squibb
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Non-Small Cell Lung Cancer

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

For more information regarding BMS clinical trial participation, please visit www.BMSStudyConnect.com

Inclusion Criteria:

  • Histologically confirmed locally advanced or stage IV NSCLC
  • Eastern Cooperative Oncology Group (ECOG) Performance status (PS) 0-2
  • Tumor tissue sections must be available for biomarker evaluation

Exclusion Criteria:

  • Untreated or active/progressing Central Nervous system (CNS) metastases
  • Active, known or suspected autoimmune disease
  • Known history of testing positive for HIV or AIDS
  • Active or chronic infection of hepatitis B virus or hepatitis C

Sites / Locations

  • Alabama Oncology
  • Southern Cancer Center Pc
  • Arizona Oncology Assoc, Pc-Hal
  • Northern Arizona Hematology & Oncology Associates
  • Arizona Oncol Assoc Dba (Hem Onc Physicians&Extenders) Hope
  • Arizona Clinical Research Center, Inc.
  • Comprehensive Blood And Cancer Center
  • St. Joseph Heritage Medical Group
  • Scripps Cancer Center
  • UCLA Hematology/Oncology Clinic
  • Coastal Integrative Cancer Care
  • Central Coast Med Oncology
  • Local Institution
  • St. Mary's Hospital Regional Cancer Center
  • Rocky Mountain Cancer Centers
  • Eastern Ct Hem Onc Assoc
  • Stamford Hospital
  • Va Ct Healthcare System
  • Florida Cancer Specialists S.
  • University of Florida at Shands
  • Memorial Cancer Institute
  • Baptist Health Medical Group Oncology
  • Ocala Oncology Center
  • Hematology Oncology Associates Of The Treasure Coast
  • Florida Cancer Specialists
  • Tallahassee Memorial Cancer Center
  • Florida Cancer Affiliates
  • University Cancer Blood Ctr
  • Cancer Treatment Centers Of America
  • Summit Cancer Care
  • Lewis Hall Singletary Oncology Center
  • Illinois Cancer Specialists
  • Community Clinical Research Center
  • Ft. Wayne Med Onco-Hema Inc
  • Cotton-O-Neil Clinical Research Center
  • West KY Hematology Oncology Group PSC
  • Christus St. Francis Cabrini Cancer Center
  • East Jefferson General Hospital
  • New England Cancer Specialists
  • Anne Arundel Medical Center
  • University Of Maryland
  • Sinai Hospital Of Baltimore
  • Center For Cancer And Blood Disorders
  • Maryland Oncology Hematology, P.A.
  • Bay Hematology Oncology
  • Cancer & Hematology Centers Of Western Michigan
  • Minnesota Oncology Hematology, P.A.
  • Forrest General Cancer Center
  • Jackson Oncology Associates, Pllc
  • St. Louis Cancer Care, Llp
  • Saint Vincent Frontier Cancer Center
  • Southeast Nebraska Cancer Center
  • Nebraska Cancer Specialists
  • Comprehensive Cancer Centers of Nevada
  • Hunterdon Medical Center
  • Summit Medical Group
  • Atlantic Health System
  • Morristown Medical Center
  • San Juan Oncology Associates
  • New York Oncology Hematology, Pc
  • Glens Falls Hospital
  • Broome Oncology
  • Northern Westchester Hospital
  • Columbia University Medical Center (Cumc)
  • Hematology-Oncology Associates Of Rockland
  • White Plains Hospital
  • Cone Health Cancer Center
  • Moses Cone Health System
  • Randolph Cancer Center
  • First Health Of The Carolinas
  • W.G. Bill Hefner VA Medical Center
  • Cancer Care Center
  • Sanford Health
  • Oncology Hematology Care, Inc.
  • Louis Stokes Cleveland VA Medical Center
  • MetroHealth Medical Center
  • Mid Ohio Oncology Hematology
  • Oklahoma Cancer Specialists and Research Institute, LLC-Clinical Research
  • Oncology Associates Of Oregon, Pc
  • Hematology Oncology Associates
  • Lehigh Valley Hospital
  • St. Luke's University Hospital Bethlehem
  • Erie Regional Cancer Center
  • Abington Hematology Oncology Associates, Inc
  • Charleston Hematology Oncology Associates, Pa
  • Greenville Health System
  • Sanford Research
  • Chattanooga Oncology Hematology Associates
  • The Jones Clinic, PC
  • West Cancer Center
  • Tennessee Oncology, PLLC - SCRI - PPDS
  • Texas Oncology-Abilene
  • Texas Oncology - Amarillo
  • Texas Oncology-Arlington North
  • Texas Oncology-Central Austin Cancer Center
  • Texas Oncology-Beaumont
  • Texas Oncology
  • Texas Oncology/Methodist Charlton Cancer Ctr
  • Texas Oncology
  • Texas Oncology
  • Texas Oncology, P.A.
  • Texas Oncology
  • Texas Oncology
  • Texas Oncology
  • Brooke Army Medical Center
  • Texas Oncology
  • The Center For Cancer And Blood Disorders
  • Texas Oncology
  • MD Anderson Cancer Center
  • Texas Cancer Center Of Mesquite
  • Texas Oncology, Pa
  • Texas Oncology
  • Texas Oncology
  • Texas Oncology-Plano East
  • Texas Oncology Plano West Cancer Center
  • Cancer Centers of South Texas
  • Texas Cancer Center - Sherman
  • Texas Oncology Cancer Center - Sugar Land
  • Texas Oncology-Tyler
  • Texas Oncology Cancer Care And Research Center
  • Texas Oncology, P.A.
  • Texas Oncology
  • Texas Oncology-Wichita Falls
  • Oncology & Hematology Associates Of Southwest Virginia, Inc.
  • Virginia Cancer Specialists, Pc
  • Virginia Oncology Associates
  • Virginia Cancer Institute
  • Shenandoah Oncology
  • Providence Regional Cancer Partnership
  • Cancer Care Northwest
  • Northwest Cancer Specialists, Pc
  • Yakima Valley Memorial Hospital/North Star Lodge
  • Edwards Comprehensive Cancer Center

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm 5

Arm 6

Arm 7

Arm 8

Arm 9

Arm 10

Arm Type

Experimental

Experimental

Active Comparator

Experimental

Other

Active Comparator

Experimental

Active Comparator

Experimental

Experimental

Arm Label

Group A Nivolumab

Group A Nivolumab + SOC maintenance therapy

Group A SOC maintenance therapy

Group B Nivolumab

Group B Best supportive care

Group C Investigator's choice chemotherapy

Group C Nivolumb

Group D Erlotinib

Group D Nivolumab + Erlotinib

Group E Nivolumab + Crizotinib

Arm Description

Opdivo specified dose on specified days

Opdivo/Bevacizumab specified dose on specified days Opdivo/Pemetrexed specified dose on specified days

Bevacizumab specified dose on specified days Pemetrexed specified dose on specified days

Opdivo specified dose on specified days

Therapy directed against specific symptoms of disease, i.e., palliative radiation or palliative surgery

Carboplatin/nab-paclitaxel specified dose on specified days Carboplatin/paclitaxel specified dose on specified days Carboplatin/pemetrexed specified dose on specified days Carboplatin/docetaxel specified dose on specified days Carboplatin/gemcitabine specified dose on specified days Paclitaxel specified dose on specified days Docetaxel specified dose on specified days Gemcitabine specified dose on specified days Pemetrexed specified dose on specified days

Opdivo specified dose on specified days

Erlotinib specified dose on specified days

Opdivo/Erlotnib specified dose on specified days

Opdivo/Crizotinib specified dose on specified days

Outcomes

Primary Outcome Measures

Progression-Free Survival (PFS), Groups A-D Only
Progression-free survival (PFS) is defined as the time from randomization to the date of the first documented tumor progression, as determined by investigators (per RECIST v1.1), or death due to any cause, whichever occurs first.
Overall Survival (OS), Groups A-C Only
Overall survival (OS) is defined as the time from randomization to the date of death.
Percentage of Participants With Treatment-related Adverse Events (AEs) Leading to Both Study Drugs Discontinuation, Group E Only
Percentage of participants who experienced a treatment-related AE during the course of the study that lead to discontinuation of both study drugs.

Secondary Outcome Measures

Duration of Response (DOR), Groups A-D Only
Duration of response (DOR) is defined as the time from first confirmed response (complete response (CR) or partial response (PR)) to the date of the initial objectively documented tumor progression as determined using RECIST 1.1 criteria or death due to any cause, whichever occurs first. Median computed using Kaplan-Meier method.
Objective Response Rate (ORR), Groups A-E
Objective response rate (ORR) is defined as the number and percentage of participants with a best overall response (BOR) of confirmed complete response (CR) or partial response (PR). Best overall response (BOR) is defined as the best response designation, recorded between the date of first dose and the date of the initial objectively documented tumor progression per RECIST v1.1 or the date of subsequent therapy, whichever occurs first. Confidence interval based on the Clopper and Pearson method.
Overall Survival (OS), Group D Only
Overall survival (OS) is defined as the time from randomization to the date of death.
Progression-Free Survival (PFS), Group E Only
Progression-free survival (PFS) is defined as the time from randomization to the date of the first documented tumor progression, as determined by investigators (per RECIST v1.1), or death due to any cause, whichever occurs first.

Full Information

First Posted
October 9, 2015
Last Updated
April 12, 2021
Sponsor
Bristol-Myers Squibb
search

1. Study Identification

Unique Protocol Identification Number
NCT02574078
Brief Title
A Study of Nivolumab in Advanced Non-Small Cell Lung Cancer (NSCLC)
Acronym
CheckMate370
Official Title
A Master Protocol of Phase 1/2 Studies of Nivolumab in Advanced NSCLC Using Nivolumab as Maintenance After Induction Chemotherapy or as First-line Treatment Alone or in Combination With Standard of Care Therapies (CheckMate 370: CHECKpoint Pathway and nivoluMAb Clinical Trial Evaluation 370)
Study Type
Interventional

2. Study Status

Record Verification Date
April 2021
Overall Recruitment Status
Completed
Study Start Date
November 23, 2015 (Actual)
Primary Completion Date
April 15, 2020 (Actual)
Study Completion Date
April 15, 2020 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Bristol-Myers Squibb

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The purpose of this study is to determine whether nivolumab monotherapy or in combination with Standard of care (SOC) therapies will provide clinical benefit (i.e., PFS, OS, and DOR) without unacceptable toxicity in advanced Non-Small Cell Lung Cancer patients.
Detailed Description
Epidermal Growth Factor Receptor (EGFR), Anaplastic Lymphoma Kinase (ALK) **Please note that the study is no longer enrolling patients for Groups A, B, C, and E.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Non-Small Cell Lung Cancer

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 1, Phase 2
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
341 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Group A Nivolumab
Arm Type
Experimental
Arm Description
Opdivo specified dose on specified days
Arm Title
Group A Nivolumab + SOC maintenance therapy
Arm Type
Experimental
Arm Description
Opdivo/Bevacizumab specified dose on specified days Opdivo/Pemetrexed specified dose on specified days
Arm Title
Group A SOC maintenance therapy
Arm Type
Active Comparator
Arm Description
Bevacizumab specified dose on specified days Pemetrexed specified dose on specified days
Arm Title
Group B Nivolumab
Arm Type
Experimental
Arm Description
Opdivo specified dose on specified days
Arm Title
Group B Best supportive care
Arm Type
Other
Arm Description
Therapy directed against specific symptoms of disease, i.e., palliative radiation or palliative surgery
Arm Title
Group C Investigator's choice chemotherapy
Arm Type
Active Comparator
Arm Description
Carboplatin/nab-paclitaxel specified dose on specified days Carboplatin/paclitaxel specified dose on specified days Carboplatin/pemetrexed specified dose on specified days Carboplatin/docetaxel specified dose on specified days Carboplatin/gemcitabine specified dose on specified days Paclitaxel specified dose on specified days Docetaxel specified dose on specified days Gemcitabine specified dose on specified days Pemetrexed specified dose on specified days
Arm Title
Group C Nivolumb
Arm Type
Experimental
Arm Description
Opdivo specified dose on specified days
Arm Title
Group D Erlotinib
Arm Type
Active Comparator
Arm Description
Erlotinib specified dose on specified days
Arm Title
Group D Nivolumab + Erlotinib
Arm Type
Experimental
Arm Description
Opdivo/Erlotnib specified dose on specified days
Arm Title
Group E Nivolumab + Crizotinib
Arm Type
Experimental
Arm Description
Opdivo/Crizotinib specified dose on specified days
Intervention Type
Drug
Intervention Name(s)
Nivolumab
Other Intervention Name(s)
Opdivo
Intervention Type
Drug
Intervention Name(s)
Bevacizumab
Intervention Type
Drug
Intervention Name(s)
Pemetrexed
Intervention Type
Other
Intervention Name(s)
Best Supportive Care
Intervention Description
Palliative radiation, palliative surgery and/or other best supportive care treatments
Intervention Type
Drug
Intervention Name(s)
nab-Paclitaxel
Intervention Type
Drug
Intervention Name(s)
Paclitaxel
Intervention Type
Drug
Intervention Name(s)
Docetaxel
Intervention Type
Drug
Intervention Name(s)
Gemcitabine
Intervention Type
Drug
Intervention Name(s)
Erlotinib
Intervention Type
Drug
Intervention Name(s)
Crizotinib
Intervention Type
Drug
Intervention Name(s)
Carboplatin
Primary Outcome Measure Information:
Title
Progression-Free Survival (PFS), Groups A-D Only
Description
Progression-free survival (PFS) is defined as the time from randomization to the date of the first documented tumor progression, as determined by investigators (per RECIST v1.1), or death due to any cause, whichever occurs first.
Time Frame
up to approximately 48 months
Title
Overall Survival (OS), Groups A-C Only
Description
Overall survival (OS) is defined as the time from randomization to the date of death.
Time Frame
up to approximately 60 months
Title
Percentage of Participants With Treatment-related Adverse Events (AEs) Leading to Both Study Drugs Discontinuation, Group E Only
Description
Percentage of participants who experienced a treatment-related AE during the course of the study that lead to discontinuation of both study drugs.
Time Frame
up to approximately 60 months
Secondary Outcome Measure Information:
Title
Duration of Response (DOR), Groups A-D Only
Description
Duration of response (DOR) is defined as the time from first confirmed response (complete response (CR) or partial response (PR)) to the date of the initial objectively documented tumor progression as determined using RECIST 1.1 criteria or death due to any cause, whichever occurs first. Median computed using Kaplan-Meier method.
Time Frame
up to approximately 48 months
Title
Objective Response Rate (ORR), Groups A-E
Description
Objective response rate (ORR) is defined as the number and percentage of participants with a best overall response (BOR) of confirmed complete response (CR) or partial response (PR). Best overall response (BOR) is defined as the best response designation, recorded between the date of first dose and the date of the initial objectively documented tumor progression per RECIST v1.1 or the date of subsequent therapy, whichever occurs first. Confidence interval based on the Clopper and Pearson method.
Time Frame
up to approximately 48 months
Title
Overall Survival (OS), Group D Only
Description
Overall survival (OS) is defined as the time from randomization to the date of death.
Time Frame
up to approximately 60 months
Title
Progression-Free Survival (PFS), Group E Only
Description
Progression-free survival (PFS) is defined as the time from randomization to the date of the first documented tumor progression, as determined by investigators (per RECIST v1.1), or death due to any cause, whichever occurs first.
Time Frame
up to approximately 48 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
For more information regarding BMS clinical trial participation, please visit www.BMSStudyConnect.com Inclusion Criteria: Histologically confirmed locally advanced or stage IV NSCLC Eastern Cooperative Oncology Group (ECOG) Performance status (PS) 0-2 Tumor tissue sections must be available for biomarker evaluation Exclusion Criteria: Untreated or active/progressing Central Nervous system (CNS) metastases Active, known or suspected autoimmune disease Known history of testing positive for HIV or AIDS Active or chronic infection of hepatitis B virus or hepatitis C
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Bristol Myers Squibb
Organizational Affiliation
Bristol-Myers Squibb
Official's Role
Study Director
Facility Information:
Facility Name
Alabama Oncology
City
Birmingham
State/Province
Alabama
ZIP/Postal Code
35205
Country
United States
Facility Name
Southern Cancer Center Pc
City
Mobile
State/Province
Alabama
ZIP/Postal Code
36608
Country
United States
Facility Name
Arizona Oncology Assoc, Pc-Hal
City
Glendale
State/Province
Arizona
ZIP/Postal Code
85308
Country
United States
Facility Name
Northern Arizona Hematology & Oncology Associates
City
Sedona
State/Province
Arizona
ZIP/Postal Code
86336
Country
United States
Facility Name
Arizona Oncol Assoc Dba (Hem Onc Physicians&Extenders) Hope
City
Tucson
State/Province
Arizona
ZIP/Postal Code
85704
Country
United States
Facility Name
Arizona Clinical Research Center, Inc.
City
Tucson
State/Province
Arizona
ZIP/Postal Code
85715
Country
United States
Facility Name
Comprehensive Blood And Cancer Center
City
Bakersfield
State/Province
California
ZIP/Postal Code
93309
Country
United States
Facility Name
St. Joseph Heritage Medical Group
City
Fullerton
State/Province
California
ZIP/Postal Code
92835
Country
United States
Facility Name
Scripps Cancer Center
City
La Jolla
State/Province
California
ZIP/Postal Code
92037
Country
United States
Facility Name
UCLA Hematology/Oncology Clinic
City
Los Angeles
State/Province
California
ZIP/Postal Code
90095
Country
United States
Facility Name
Coastal Integrative Cancer Care
City
San Luis Obispo
State/Province
California
ZIP/Postal Code
93401
Country
United States
Facility Name
Central Coast Med Oncology
City
Santa Maria
State/Province
California
ZIP/Postal Code
93454
Country
United States
Facility Name
Local Institution
City
Solvang
State/Province
California
ZIP/Postal Code
93463
Country
United States
Facility Name
St. Mary's Hospital Regional Cancer Center
City
Grand Junction
State/Province
Colorado
ZIP/Postal Code
81501
Country
United States
Facility Name
Rocky Mountain Cancer Centers
City
Lakewood
State/Province
Colorado
ZIP/Postal Code
80228
Country
United States
Facility Name
Eastern Ct Hem Onc Assoc
City
Norwich
State/Province
Connecticut
ZIP/Postal Code
06360
Country
United States
Facility Name
Stamford Hospital
City
Stamford
State/Province
Connecticut
ZIP/Postal Code
06904
Country
United States
Facility Name
Va Ct Healthcare System
City
West Haven
State/Province
Connecticut
ZIP/Postal Code
06516
Country
United States
Facility Name
Florida Cancer Specialists S.
City
Fort Myers
State/Province
Florida
ZIP/Postal Code
33901
Country
United States
Facility Name
University of Florida at Shands
City
Gainesville
State/Province
Florida
ZIP/Postal Code
32610
Country
United States
Facility Name
Memorial Cancer Institute
City
Hollywood
State/Province
Florida
ZIP/Postal Code
33201
Country
United States
Facility Name
Baptist Health Medical Group Oncology
City
Miami
State/Province
Florida
ZIP/Postal Code
33176
Country
United States
Facility Name
Ocala Oncology Center
City
Ocala
State/Province
Florida
ZIP/Postal Code
34471
Country
United States
Facility Name
Hematology Oncology Associates Of The Treasure Coast
City
Port Saint Lucie
State/Province
Florida
ZIP/Postal Code
34952
Country
United States
Facility Name
Florida Cancer Specialists
City
Saint Petersburg
State/Province
Florida
ZIP/Postal Code
33705
Country
United States
Facility Name
Tallahassee Memorial Cancer Center
City
Tallahassee
State/Province
Florida
ZIP/Postal Code
32308
Country
United States
Facility Name
Florida Cancer Affiliates
City
Trinity
State/Province
Florida
ZIP/Postal Code
34655
Country
United States
Facility Name
University Cancer Blood Ctr
City
Athens
State/Province
Georgia
ZIP/Postal Code
30607
Country
United States
Facility Name
Cancer Treatment Centers Of America
City
Newnan
State/Province
Georgia
ZIP/Postal Code
30265
Country
United States
Facility Name
Summit Cancer Care
City
Savannah
State/Province
Georgia
ZIP/Postal Code
31405
Country
United States
Facility Name
Lewis Hall Singletary Oncology Center
City
Thomasville
State/Province
Georgia
ZIP/Postal Code
31792
Country
United States
Facility Name
Illinois Cancer Specialists
City
Niles
State/Province
Illinois
ZIP/Postal Code
60714
Country
United States
Facility Name
Community Clinical Research Center
City
Anderson
State/Province
Indiana
ZIP/Postal Code
46011
Country
United States
Facility Name
Ft. Wayne Med Onco-Hema Inc
City
Fort Wayne
State/Province
Indiana
ZIP/Postal Code
46845
Country
United States
Facility Name
Cotton-O-Neil Clinical Research Center
City
Topeka
State/Province
Kansas
ZIP/Postal Code
66606
Country
United States
Facility Name
West KY Hematology Oncology Group PSC
City
Paducah
State/Province
Kentucky
ZIP/Postal Code
42003
Country
United States
Facility Name
Christus St. Francis Cabrini Cancer Center
City
Alexandria
State/Province
Louisiana
ZIP/Postal Code
71301
Country
United States
Facility Name
East Jefferson General Hospital
City
Metairie
State/Province
Louisiana
ZIP/Postal Code
70006
Country
United States
Facility Name
New England Cancer Specialists
City
Scarborough
State/Province
Maine
ZIP/Postal Code
04074
Country
United States
Facility Name
Anne Arundel Medical Center
City
Annapolis
State/Province
Maryland
ZIP/Postal Code
21401
Country
United States
Facility Name
University Of Maryland
City
Baltimore
State/Province
Maryland
ZIP/Postal Code
21201
Country
United States
Facility Name
Sinai Hospital Of Baltimore
City
Baltimore
State/Province
Maryland
ZIP/Postal Code
21215
Country
United States
Facility Name
Center For Cancer And Blood Disorders
City
Bethesda
State/Province
Maryland
ZIP/Postal Code
20817
Country
United States
Facility Name
Maryland Oncology Hematology, P.A.
City
Columbia
State/Province
Maryland
ZIP/Postal Code
21044
Country
United States
Facility Name
Bay Hematology Oncology
City
Easton
State/Province
Maryland
ZIP/Postal Code
21601
Country
United States
Facility Name
Cancer & Hematology Centers Of Western Michigan
City
Grand Rapids
State/Province
Michigan
ZIP/Postal Code
49503
Country
United States
Facility Name
Minnesota Oncology Hematology, P.A.
City
Edina
State/Province
Minnesota
ZIP/Postal Code
55435
Country
United States
Facility Name
Forrest General Cancer Center
City
Hattiesburg
State/Province
Mississippi
ZIP/Postal Code
39401
Country
United States
Facility Name
Jackson Oncology Associates, Pllc
City
Jackson
State/Province
Mississippi
ZIP/Postal Code
39202
Country
United States
Facility Name
St. Louis Cancer Care, Llp
City
Bridgeton
State/Province
Missouri
ZIP/Postal Code
63044
Country
United States
Facility Name
Saint Vincent Frontier Cancer Center
City
Billings
State/Province
Montana
ZIP/Postal Code
59105
Country
United States
Facility Name
Southeast Nebraska Cancer Center
City
Lincoln
State/Province
Nebraska
ZIP/Postal Code
68510
Country
United States
Facility Name
Nebraska Cancer Specialists
City
Omaha
State/Province
Nebraska
ZIP/Postal Code
68130
Country
United States
Facility Name
Comprehensive Cancer Centers of Nevada
City
Las Vegas
State/Province
Nevada
ZIP/Postal Code
89128
Country
United States
Facility Name
Hunterdon Medical Center
City
Flemington
State/Province
New Jersey
ZIP/Postal Code
08822
Country
United States
Facility Name
Summit Medical Group
City
Morristown
State/Province
New Jersey
ZIP/Postal Code
07960
Country
United States
Facility Name
Atlantic Health System
City
Summit
State/Province
New Jersey
ZIP/Postal Code
07901
Country
United States
Facility Name
Morristown Medical Center
City
Summit
State/Province
New Jersey
ZIP/Postal Code
07901
Country
United States
Facility Name
San Juan Oncology Associates
City
Farmington
State/Province
New Mexico
ZIP/Postal Code
87401
Country
United States
Facility Name
New York Oncology Hematology, Pc
City
Albany
State/Province
New York
ZIP/Postal Code
12208
Country
United States
Facility Name
Glens Falls Hospital
City
Glens Falls
State/Province
New York
ZIP/Postal Code
12801
Country
United States
Facility Name
Broome Oncology
City
Johnson City
State/Province
New York
ZIP/Postal Code
13790
Country
United States
Facility Name
Northern Westchester Hospital
City
Mount Kisco
State/Province
New York
ZIP/Postal Code
10549
Country
United States
Facility Name
Columbia University Medical Center (Cumc)
City
New York
State/Province
New York
ZIP/Postal Code
10032
Country
United States
Facility Name
Hematology-Oncology Associates Of Rockland
City
Nyack
State/Province
New York
ZIP/Postal Code
10960
Country
United States
Facility Name
White Plains Hospital
City
White Plains
State/Province
New York
ZIP/Postal Code
10601
Country
United States
Facility Name
Cone Health Cancer Center
City
Greensboro
State/Province
North Carolina
ZIP/Postal Code
27403
Country
United States
Facility Name
Moses Cone Health System
City
Greensboro
State/Province
North Carolina
ZIP/Postal Code
27403
Country
United States
Facility Name
Randolph Cancer Center
City
Greensboro
State/Province
North Carolina
ZIP/Postal Code
27403
Country
United States
Facility Name
First Health Of The Carolinas
City
Pinehurst
State/Province
North Carolina
ZIP/Postal Code
28374
Country
United States
Facility Name
W.G. Bill Hefner VA Medical Center
City
Salisbury
State/Province
North Carolina
ZIP/Postal Code
28144
Country
United States
Facility Name
Cancer Care Center
City
Bismarck
State/Province
North Dakota
ZIP/Postal Code
58501
Country
United States
Facility Name
Sanford Health
City
Fargo
State/Province
North Dakota
ZIP/Postal Code
58122
Country
United States
Facility Name
Oncology Hematology Care, Inc.
City
Cincinnati
State/Province
Ohio
ZIP/Postal Code
45242
Country
United States
Facility Name
Louis Stokes Cleveland VA Medical Center
City
Cleveland
State/Province
Ohio
ZIP/Postal Code
44106-1702
Country
United States
Facility Name
MetroHealth Medical Center
City
Cleveland
State/Province
Ohio
ZIP/Postal Code
44109
Country
United States
Facility Name
Mid Ohio Oncology Hematology
City
Columbus
State/Province
Ohio
ZIP/Postal Code
43219
Country
United States
Facility Name
Oklahoma Cancer Specialists and Research Institute, LLC-Clinical Research
City
Tulsa
State/Province
Oklahoma
ZIP/Postal Code
74146
Country
United States
Facility Name
Oncology Associates Of Oregon, Pc
City
Eugene
State/Province
Oregon
ZIP/Postal Code
97401
Country
United States
Facility Name
Hematology Oncology Associates
City
Medford
State/Province
Oregon
ZIP/Postal Code
97504
Country
United States
Facility Name
Lehigh Valley Hospital
City
Allentown
State/Province
Pennsylvania
ZIP/Postal Code
18103
Country
United States
Facility Name
St. Luke's University Hospital Bethlehem
City
Bethlehem
State/Province
Pennsylvania
ZIP/Postal Code
18015
Country
United States
Facility Name
Erie Regional Cancer Center
City
Erie
State/Province
Pennsylvania
ZIP/Postal Code
16505
Country
United States
Facility Name
Abington Hematology Oncology Associates, Inc
City
Horsham
State/Province
Pennsylvania
ZIP/Postal Code
18944
Country
United States
Facility Name
Charleston Hematology Oncology Associates, Pa
City
Charleston
State/Province
South Carolina
ZIP/Postal Code
29414
Country
United States
Facility Name
Greenville Health System
City
Greenville
State/Province
South Carolina
ZIP/Postal Code
29615
Country
United States
Facility Name
Sanford Research
City
Sioux Falls
State/Province
South Dakota
ZIP/Postal Code
57104
Country
United States
Facility Name
Chattanooga Oncology Hematology Associates
City
Chattanooga
State/Province
Tennessee
ZIP/Postal Code
37404
Country
United States
Facility Name
The Jones Clinic, PC
City
Germantown
State/Province
Tennessee
ZIP/Postal Code
38138
Country
United States
Facility Name
West Cancer Center
City
Germantown
State/Province
Tennessee
ZIP/Postal Code
38138
Country
United States
Facility Name
Tennessee Oncology, PLLC - SCRI - PPDS
City
Nashville
State/Province
Tennessee
ZIP/Postal Code
37203
Country
United States
Facility Name
Texas Oncology-Abilene
City
Abilene
State/Province
Texas
ZIP/Postal Code
79606
Country
United States
Facility Name
Texas Oncology - Amarillo
City
Amarillo
State/Province
Texas
ZIP/Postal Code
79106
Country
United States
Facility Name
Texas Oncology-Arlington North
City
Arlington
State/Province
Texas
ZIP/Postal Code
76012
Country
United States
Facility Name
Texas Oncology-Central Austin Cancer Center
City
Austin
State/Province
Texas
ZIP/Postal Code
78745
Country
United States
Facility Name
Texas Oncology-Beaumont
City
Beaumont
State/Province
Texas
ZIP/Postal Code
77702
Country
United States
Facility Name
Texas Oncology
City
Bedford
State/Province
Texas
ZIP/Postal Code
76022
Country
United States
Facility Name
Texas Oncology/Methodist Charlton Cancer Ctr
City
Dallas
State/Province
Texas
ZIP/Postal Code
75203
Country
United States
Facility Name
Texas Oncology
City
Dallas
State/Province
Texas
ZIP/Postal Code
75230
Country
United States
Facility Name
Texas Oncology
City
Dallas
State/Province
Texas
ZIP/Postal Code
75231
Country
United States
Facility Name
Texas Oncology, P.A.
City
Dallas
State/Province
Texas
ZIP/Postal Code
75246
Country
United States
Facility Name
Texas Oncology
City
Denton
State/Province
Texas
ZIP/Postal Code
76201
Country
United States
Facility Name
Texas Oncology
City
El Paso
State/Province
Texas
ZIP/Postal Code
79902
Country
United States
Facility Name
Texas Oncology
City
Flower Mound
State/Province
Texas
ZIP/Postal Code
75028
Country
United States
Facility Name
Brooke Army Medical Center
City
Fort Sam Houston
State/Province
Texas
ZIP/Postal Code
78234
Country
United States
Facility Name
Texas Oncology
City
Fort Worth
State/Province
Texas
ZIP/Postal Code
76104
Country
United States
Facility Name
The Center For Cancer And Blood Disorders
City
Fort Worth
State/Province
Texas
ZIP/Postal Code
76104
Country
United States
Facility Name
Texas Oncology
City
Houston
State/Province
Texas
ZIP/Postal Code
77024
Country
United States
Facility Name
MD Anderson Cancer Center
City
Houston
State/Province
Texas
ZIP/Postal Code
77030
Country
United States
Facility Name
Texas Cancer Center Of Mesquite
City
Mesquite
State/Province
Texas
ZIP/Postal Code
75150
Country
United States
Facility Name
Texas Oncology, Pa
City
Midland
State/Province
Texas
ZIP/Postal Code
79701
Country
United States
Facility Name
Texas Oncology
City
New Braunfels
State/Province
Texas
ZIP/Postal Code
78130
Country
United States
Facility Name
Texas Oncology
City
Paris
State/Province
Texas
ZIP/Postal Code
75460
Country
United States
Facility Name
Texas Oncology-Plano East
City
Plano
State/Province
Texas
ZIP/Postal Code
75075-7787
Country
United States
Facility Name
Texas Oncology Plano West Cancer Center
City
Plano
State/Province
Texas
ZIP/Postal Code
75093
Country
United States
Facility Name
Cancer Centers of South Texas
City
San Antonio
State/Province
Texas
ZIP/Postal Code
78212
Country
United States
Facility Name
Texas Cancer Center - Sherman
City
Sherman
State/Province
Texas
ZIP/Postal Code
75090
Country
United States
Facility Name
Texas Oncology Cancer Center - Sugar Land
City
Sugar Land
State/Province
Texas
ZIP/Postal Code
77479
Country
United States
Facility Name
Texas Oncology-Tyler
City
Tyler
State/Province
Texas
ZIP/Postal Code
75702
Country
United States
Facility Name
Texas Oncology Cancer Care And Research Center
City
Waco
State/Province
Texas
ZIP/Postal Code
76712
Country
United States
Facility Name
Texas Oncology, P.A.
City
Webster
State/Province
Texas
ZIP/Postal Code
77598-4420
Country
United States
Facility Name
Texas Oncology
City
Weslaco
State/Province
Texas
ZIP/Postal Code
78596
Country
United States
Facility Name
Texas Oncology-Wichita Falls
City
Wichita Falls
State/Province
Texas
ZIP/Postal Code
76310
Country
United States
Facility Name
Oncology & Hematology Associates Of Southwest Virginia, Inc.
City
Blacksburg
State/Province
Virginia
ZIP/Postal Code
24060
Country
United States
Facility Name
Virginia Cancer Specialists, Pc
City
Fairfax
State/Province
Virginia
ZIP/Postal Code
22031
Country
United States
Facility Name
Virginia Oncology Associates
City
Norfolk
State/Province
Virginia
ZIP/Postal Code
23502
Country
United States
Facility Name
Virginia Cancer Institute
City
Richmond
State/Province
Virginia
ZIP/Postal Code
23230
Country
United States
Facility Name
Shenandoah Oncology
City
Winchester
State/Province
Virginia
ZIP/Postal Code
22601
Country
United States
Facility Name
Providence Regional Cancer Partnership
City
Everett
State/Province
Washington
ZIP/Postal Code
98201
Country
United States
Facility Name
Cancer Care Northwest
City
Spokane Valley
State/Province
Washington
ZIP/Postal Code
99216
Country
United States
Facility Name
Northwest Cancer Specialists, Pc
City
Vancouver
State/Province
Washington
ZIP/Postal Code
98684
Country
United States
Facility Name
Yakima Valley Memorial Hospital/North Star Lodge
City
Yakima
State/Province
Washington
ZIP/Postal Code
98902
Country
United States
Facility Name
Edwards Comprehensive Cancer Center
City
Huntington
State/Province
West Virginia
ZIP/Postal Code
25701
Country
United States

12. IPD Sharing Statement

Links:
URL
https://www.bms.com/researchers-and-partners/clinical-trials-and-research.html
Description
BMS Clinical Trial Information
URL
https://www.bmsstudyconnect.com/s/US/English/USenHome
Description
BMS Clinical Trial Patient Recruiting
URL
https://www.fda.gov/Safety/MedWatch/SafetyInformation/default.htm
Description
FDA Safety Alerts and Recalls

Learn more about this trial

A Study of Nivolumab in Advanced Non-Small Cell Lung Cancer (NSCLC)

We'll reach out to this number within 24 hrs